These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30649240)

  • 21. Prognostic Value of Right Ventricular Dysfunction in Patients With AL Amyloidosis: Comparison of Different Techniques by Cardiac Magnetic Resonance.
    Wan K; Lin J; Guo X; Song R; Wang J; Xu Y; Li W; Cheng W; Sun J; Zhang Q; Han Y; Chen Y
    J Magn Reson Imaging; 2020 Nov; 52(5):1441-1448. PubMed ID: 32691470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
    Ternacle J; Bodez D; Guellich A; Audureau E; Rappeneau S; Lim P; Radu C; Guendouz S; Couetil JP; Benhaiem N; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Mohty D; Deux JF; Damy T
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):126-38. PubMed ID: 26777222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness.
    Holcman K; Kostkiewicz M; Szot W; Ćmiel B; Mróz K; Stępień A; Graczyk K; Dziewięcka E; Karabinowska-Małocha A; Sachajko Z; Podolec P; Rubiś P
    Int J Cardiovasc Imaging; 2024 Aug; 40(8):1693-1703. PubMed ID: 38856962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders.
    López-Sainz Á; de Haro-Del Moral FJ; Dominguez F; Restrepo-Cordoba A; Amor-Salamanca A; Hernandez-Hernandez A; Ruiz-Guerrero L; Krsnik I; Cobo-Marcos M; Castro V; Toquero-Ramos J; Lara-Pezzi E; Fernandez-Lozano I; Alonso-Pulpon L; González-López E; Garcia-Pavia P
    Amyloid; 2019 Sep; 26(3):156-163. PubMed ID: 31210553
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis.
    Arenja N; Andre F; Riffel JH; Siepen FAD; Hegenbart U; Schönland S; Kristen AV; Katus HA; Buss SJ
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):53. PubMed ID: 31434577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac Amyloidosis: Mimics, Multimodality Imaging Diagnosis, and Treatment.
    Fazlinezhad A; Naqvi TZ
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1384-1391. PubMed ID: 32061555
    [No Abstract]   [Full Text] [Related]  

  • 27. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
    Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality.
    Sanchis K; Cariou E; Colombat M; Ribes D; Huart A; Cintas P; Fournier P; Rollin A; Carrié D; Galinier M; Maury P; Duparc A; Lairez O;
    Amyloid; 2019 Sep; 26(3):128-138. PubMed ID: 31172799
    [No Abstract]   [Full Text] [Related]  

  • 29. Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis.
    Liu D; Hu K; Herrmann S; Cikes M; Ertl G; Weidemann F; Störk S; Nordbeck P
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):837-845. PubMed ID: 28265790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis.
    Annabi MS; Carter-Storch R; Zaroui A; Galat A; Oghina S; Kharoubi M; Bezard M; Derumeaux G; Fanen P; Lemonnier F; Poullot E; Itti E; Gallet R; Teiger E; Pibarot P; Damy T; Clavel MA
    J Am Heart Assoc; 2024 Jul; 13(13):e034723. PubMed ID: 38904242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Implications of Right Ventricular Systolic Dysfunction in Cardiac Amyloidosis.
    Tjahjadi C; Fortuni F; Stassen J; Debonnaire P; Lustosa RP; Marsan NA; Delgado V; Bax JJ
    Am J Cardiol; 2022 Jun; 173():120-127. PubMed ID: 35369931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parametric mapping using cardiovascular magnetic resonance for the differentiation of light chain amyloidosis and transthyretin-related amyloidosis.
    Kravchenko D; Isaak A; Zimmer S; Öztürk C; Mesropyan N; Bischoff LM; Voigt M; Ginzburg D; Attenberger U; Pieper CC; Kuetting D; Luetkens JA
    Eur Heart J Cardiovasc Imaging; 2024 Sep; 25(10):1451-1461. PubMed ID: 38912832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.
    Lei C; Zhu X; Hsi DH; Wang J; Zuo L; Ta S; Yang Q; Xu L; Zhao X; Wang Y; Sun S; Liu L
    BMC Cardiovasc Disord; 2021 Jan; 21(1):43. PubMed ID: 33478398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of right ventricular global longitudinal strain in transthyretin amyloid cardiomyopathy.
    Usuku H; Takashio S; Yamamoto E; Yamada T; Egashira K; Morioka M; Nishi M; Komorita T; Oike F; Tabata N; Ishii M; Yamanaga K; Fujisue K; Sueta D; Arima Y; Araki S; Oda S; Misumi Y; Kawano H; Matsushita K; Ueda M; Matsui H; Tsujita K
    J Cardiol; 2022 Jul; 80(1):56-63. PubMed ID: 35282945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to Image Cardiac Amyloidosis: A Practical Approach.
    Dorbala S; Cuddy S; Falk RH
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1368-1383. PubMed ID: 31607664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac amyloidosis is associated with increased aortic stiffness.
    Nemes A; Földeák D; Domsik P; Kalapos A; Kormányos Á; Borbényi Z; Forster T
    J Clin Ultrasound; 2018 Mar; 46(3):183-187. PubMed ID: 29064094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of right ventricular global longitudinal strain in patients with immunoglobulin light-chain cardiac amyloidosis.
    Usuku H; Yamamoto E; Sueta D; Noguchi M; Fujisaki T; Egashira K; Oike F; Fujisue K; Hanatani S; Arima Y; Takashio S; Kawano Y; Oda S; Kawano H; Matsushita K; Ueda M; Matsui H; Matsuoka M; Tsujita K
    Eur Heart J Open; 2023 May; 3(3):oead048. PubMed ID: 37214543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants and Prognostic Significance of Serial Right Heart Function Changes in Patients With Cardiac Amyloidosis.
    Fine NM; White JA; Jimenez-Zepeda V; Howlett JG
    Can J Cardiol; 2020 Mar; 36(3):432-440. PubMed ID: 32145870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.